H.R. 2841: FAST Generics Act of 2015

Introduced:

Jun 18, 2015

Status:

Referred to Committee on Jun 18, 2015

This bill was assigned to a congressional committee on June 18, 2015, which will consider it before possibly sending it on to the House or Senate as a whole.

Sponsor:

Steve Stivers

Representative for Ohio's 15th congressional district

Republican

Text:

Read Text »
Last Updated: Jun 18, 2015
Length: 15 pages

Prognosis:

3% chance of being enacted (details)

About the bill

Full Title

To amend the Federal Food, Drug, and Cosmetic Act to ensure that eligible product developers have competitive access to approved drugs and licensed biological products, so as to enable eligible product developers to develop and test new products, and for other purposes.

The bill’s titles are written by its sponsor.

Summary

It’s no secret that generic drugs cost less than their name-brand equivalents, for example, using other ibuprofen products besides Advil or other acetaminophen products besides Tylenol, but just how much less they cost may surprise you. According to the Food and Drug Administration (FDA), the average generic costs only 15 to 20 percent as much as its branded counterpart ...

Read more >

History

Jun 18, 2015
 
Introduced

This is the first step in the legislative process.

 
Reported by Committee

 
Passed House

 
Passed Senate

 
Signed by the President

This page is about a bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Links & tools

Primary Source

Congress.gov

Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.

Citation

Click a format for a citation suggestion: